ArticleThe Journal of clinical investigation2023

SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern.

Arturo Casadevall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.